Coverage varies by plan, but many major insurers now acknowledge semaglutide as a necessary treatment for weight management
Important Note: The telehealth weight loss industry, particularly platforms offering compounded GLP-1 medications, has been under increased regulatory scrutiny in recent years
GLP-1 receptor agonists are now becoming one of the most important therapeutic platforms in obesity and cardiometabolic disease
Results in Box plots indicate median (middle line), 25th, 75th percentile (box), and lowest, highest value (whiskers), other data are shown as the mean, and error bars represent the s.e.m
There is no distinct cause of food noise
However, coverage is not guaranteed and should be discussed with your insurance provider